POLYNUKLEOTIDE

European patent · EP3850089 · In force

Register entry

Publication number
EP3850089
Application number
EP20705470
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 4, 2020
Published
Jul 21, 2021
Granted
Dec 13, 2023
Protection ends at the latest
Feb 3, 2040
Next annual fee due
Feb 28, 2027
IPC classes
C12N 9/24 (2006.01)
A61K 38/47 (2006.01)
A61P 1/16 (2006.01)
Priority
GB 201901512 04.02.2019
GB 201917910 06.12.2019
PCT application
PCT/GB2020/050251 04.02.2020
PCT publication
WO2020/161483 13.08.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Mar 1, 2025

    Change

    Published in Swissreg on 01.03.2025

  3. Oct 23, 2024

    Change

    Published in Swissreg on 23.10.2024

  4. Mar 7, 2024

    Change

    Published in Swissreg on 07.03.2024

  5. Jan 4, 2024

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 04.01.2024

  6. Dec 13, 2023

    Granted

    Published in Swissreg on 13.12.2023

Parties

Holder

Freeline Therapeutics Limited

Sycamore House Gunnels Wood Road, Stevenage, Hertfordshire SG1 2BP, GB

Agent

Isler & Pedrazzini AG

Postfach, 8027 Zürich

Inventor

KIA, Azadeh

Stevenage, Hertfordshire SG1 2BP, GB

CORBAU, Romuald

Stevenage, Hertfordshire SG1 2BP, GB

MCINTOSH, Jenny

Stevenage, Hertfordshire SG1 2BP, GB

MIRANDA, Carlos

Stevenage, Hertfordshire SG1 2BP, GB

NATHWANI, Amit

Stevenage, Hertfordshire SG1 2BP, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.